2-amino-1-(3-chloro-4-fluorophenyl)ethanol | 153292-18-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-amino-1-(3-chloro-4-fluorophenyl)ethanol
• 英文别名: 2-Amino-1-(3-chloro-4-fluorophenyl)ethan-1-ol
• CAS: 153292-18-3
• 化学式: C₈H₉ClFNO
• 分子量: 189.617
• InChiKey: PPLFENOCMSQLTD-UHFFFAOYSA-N

物化性质

• 沸点：
  323.5±37.0 °C(Predicted)
• 密度：
  1.351±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  46.2
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-amino-1-(3-chloro-4-fluorophenyl)ethanol 、 4-chloro-6-(3-chloro-4-trifluoromethyl-phenyl)pyrimidine 在 碳酸氢钠 作用下， 以 1,4-二氧六环 为溶剂， 生成 1-[3-chloro-4-fluorophenyl]-2-({6-[3-chloro-4-(trifluoromethyl)phenyl]pyrimidin-4-yl}amino)-ethanol
  参考文献：
  名称：

  1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase

  摘要：

  A series of 1-aryl-2-(((6-aryl)pyrimidin-4-yl)amino)ethanols have been found to be competitive inhibitors of fatty acid amide hydrolase (FAAH). One member of this class, JNJ-40413269, was found to have excellent pharmacokinetic properties, demonstrated robust central target engagement, and was efficacious in a rat model of neuropathic pain. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2014.01.064
• 作为产物：
  描述：

  3-氯-4-氟苯甲醛 在 lithium aluminium tetrahydride 、 zinc(II) iodide 作用下， 以 四氢呋喃 为溶剂， 生成 2-amino-1-(3-chloro-4-fluorophenyl)ethanol
  参考文献：
  名称：

  1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase

  摘要：

  A series of 1-aryl-2-(((6-aryl)pyrimidin-4-yl)amino)ethanols have been found to be competitive inhibitors of fatty acid amide hydrolase (FAAH). One member of this class, JNJ-40413269, was found to have excellent pharmacokinetic properties, demonstrated robust central target engagement, and was efficacious in a rat model of neuropathic pain. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2014.01.064

文献信息

• [EN] BIARYL COMPOUNDS USEFUL AS IMMUNOMODULATORS<br/>[FR] COMPOSÉS BIARYLES UTILES EN TANT QU'IMMUNOMODULATEURS
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2018044963A1

  公开（公告）日：2018-03-08

  The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.

  本公开涉及通常用作免疫调节剂的化合物。本文提供了包含这些化合物的组合物，以及它们的使用方法。该公开进一步涉及包含至少一种根据本公开的化合物的药物组合物，用于治疗各种疾病，包括癌症和传染病。
• Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity
  申请人：Sankyo Company, Limited

  公开号：US05576340A1

  公开（公告）日：1996-11-19

  Compounds of formula (I): ##STR1## (wherein: R.sup.0 is hydrogen, methyl or hydroxymethyl; R.sup.1 is substituted alkyl; R.sup.2 and R.sup.3 are each hydrogen, halogen, hydroxy, alkoxy, carboxy, alkoxycarbonyl, alkyl, nitro, haloalkyl, or substituted alkyl; X is oxygen or sulfur; and Ar optionally substituted phenyl or naphthyl); and pharmaceutically acceptable salts thereof have a variety of valuable pharmaceutical activities, including anti-diabetic and anti-obesity activities; in addition, they are capable of treating or preventing hyperlipemia and hyperglycemia and, by inhibiting the action of aldose reductase, they can also be effective in the treatment and prevention of complications of diabetes.

  化合物的化学式（I）：##STR1##（其中：R.sup.0为氢、甲基或羟甲基；R.sup.1为取代烷基；R.sup.2和R.sup.3分别为氢、卤素、羟基、烷氧基、羧基、烷氧羰基、烷基、硝基、卤代烷基或取代烷基；X为氧或硫；Ar为可选的取代苯基或萘基）；以及其药学上可接受的盐具有多种有价值的药理活性，包括抗糖尿病和抗肥胖活性；此外，它们能够治疗或预防高脂血症和高血糖，并通过抑制醛糖还原酶的作用，它们还可以有效地治疗和预防糖尿病并发症。
• Compounds useful as immunomodulators
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US10144706B2

  公开（公告）日：2018-12-04

  The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.

  本公开内容一般涉及可用作免疫调节剂的化合物。本文提供了化合物、包含此类化合物的组合物及其使用方法。本公开进一步涉及包含至少一种根据本公开的化合物的药物组合物，这些组合物可用于治疗各种疾病，包括癌症和传染性疾病。
• Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase
  作者：Mark D. Wittman、Balu Balasubramanian、Karen Stoffan、Upender Velaparthi、Pieying Liu、Subramaniam Krishnanathan、Joan Carboni、Aixin Li、Ann Greer、Ricardo Attar、Marco Gottardis、Chiehying Chang、Bruce Jacobson、Yax Sun、Steven Hansel、Mary Zoeckler、Dolatrai M. Vyas

  DOI：10.1016/j.bmcl.2006.11.041

  日期：2007.2

  A novel class of 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase is described. This report discusses the SAR of 4-(2-hydroxy-2-phenylethylamino)-substituted pyridones with improved IGF-1R potency. (c) 2006 Elsevier Ltd. All rights reserved.
• Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses
  申请人：Sankyo Company Limited

  公开号：EP0543662B1

  公开（公告）日：1996-09-18